you ve been you disclosed the wrong value of shares you owned in, you know, in therapeutic. now, dr. price, this has a diversified portfolio with morgan stanley and a broker directed account. correct me if i m wrong on any of this, doctor. the portfolio includes both health care and non-health care stocks. its financial adviser designed the portfolio and directed all trades in the account. the advisers, not dr. price, has the discretion to decide which securities to buy and sell. march 17th, 2016 in a periodic rebalancing of the portfolio, the financial adviser directed the purchase of 26 shares in zimmer bionet worth more handed
those stocks. we talked a little bit about the zimmer biomed. your broker, you say, you didn t know this, bought it on march 17th, 2016. you did introduce a bill later, a week later, on march 23rd, 2016. you say you did not know then that you had the stock. it was to delay a federal rule that would have reduced the profitability of the company s joint to delay a rule that would hurt the company. what i don t understand is, once you found out that your broker bought it, you kept the stock. you purchased this 50,000 to 1 100,000 of innate immuno, we
about the zimmer biomet, your broker, you say, you did know this, bought it on march 17th, 2016. you did introduce a bill later, a week later, on march 23rd, 2016. you say that you did not know then. that you had this stock. it was to delay a federal rule that would have reduce the profitability of the companies to delay a rule that would hurt the company. what i don t understand is once you found out that your broker bought it, you kept the stock. you purchased this 50,000 to $100,000 worth of stock in a biomedical company called innate immuno. the single largest purchase in the past three years, in a
it really means you get better care at lower prices. but i know the policy is controversial, because it affects how hospitals are paid, which in turn affects how much money the manufacturers at these hip and knee replacements can make. and one of the companies is the company raised by mr. franken, as senator franken, and that is zimmer biomet. they re one of the world s leading manufacturers of hip and knees is and they make more money if they can charge higher prices and sell more of their products. the company knows this and so do the stock analysts. so on march 17th, 2016, you purchased stock in zimmer biomet. exactly six days after you bought the stock, on march 23rd, 2016, you introduced a bill in the house called the hip act that would require hhs secretary to suspend regulations, affecting the payment for hip and knee replacements. is that correct? i think the bbci program, to